These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29930239)

  • 1. Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).
    Szulawski R; Kourlas PJ; Antonchak M
    Am J Case Rep; 2018 Jun; 19():734-738. PubMed ID: 29930239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
    Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
    Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
    Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
    Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Lupus Erythematosus and Cytokine Storm.
    Caricchio R; Gallucci S
    Adv Exp Med Biol; 2024; 1448():355-364. PubMed ID: 39117826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 8. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.
    Lin Q; Zhang M; Tang H; Shen Y; Zhu Y; Xu Q; Li X
    Rheumatol Int; 2020 May; 40(5):811-819. PubMed ID: 31377830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.
    Gormezano NW; Otsuzi CI; Barros DL; da Silva MA; Pereira RM; Campos LM; Borba EF; Bonfá E; Silva CA
    Semin Arthritis Rheum; 2016 Jun; 45(6):706-10. PubMed ID: 26833399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
    Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
    Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
    Kübler L; Bittmann I; Kuipers JG
    Z Rheumatol; 2020 Dec; 79(10):1040-1045. PubMed ID: 32804304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome.
    Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
    Semin Arthritis Rheum; 2017 Oct; 47(2):216-221. PubMed ID: 28268026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
    Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
    Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
    Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
    Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eighty-six cases of clinical characteristics and outcomes of systemic lupus erythematosus-associated macrophage activation syndrome: A meta-analysis study.
    Wang J; Rong W; Yan H
    Immun Inflamm Dis; 2024 Aug; 12(8):e1364. PubMed ID: 39110110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.